313 related articles for article (PubMed ID: 16849381)
21. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
Foster PS; Denborough MA
Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
[TBL] [Abstract][Full Text] [Related]
22. Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia.
Owen VJ; Taske NL; Lamb GD
Am J Physiol; 1997 Jan; 272(1 Pt 1):C203-11. PubMed ID: 9038826
[TBL] [Abstract][Full Text] [Related]
23. Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene.
Ohnishi ST; Taylor S; Gronert GA
FEBS Lett; 1983 Sep; 161(1):103-7. PubMed ID: 6884519
[TBL] [Abstract][Full Text] [Related]
24. Effects of isoflurane, sevoflurane, and halothane on myofilament Ca2+ sensitivity and sarcoplasmic reticulum Ca2+ release in rat ventricular myocytes.
Davies LA; Gibson CN; Boyett MR; Hopkins PM; Harrison SM
Anesthesiology; 2000 Oct; 93(4):1034-44. PubMed ID: 11020759
[TBL] [Abstract][Full Text] [Related]
25. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
[TBL] [Abstract][Full Text] [Related]
26. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
[TBL] [Abstract][Full Text] [Related]
27. Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells.
Girard T; Treves S; Censier K; Mueller CR; Zorzato F; Urwyler A
Br J Anaesth; 2002 Oct; 89(4):571-9. PubMed ID: 12393358
[TBL] [Abstract][Full Text] [Related]
28. Evidence for intraluminal Ca++ regulatory site defect in sarcoplasmic reticulum from malignant hyperthermia pig muscle.
Nelson TE; Lin M; Volpe P
J Pharmacol Exp Ther; 1991 Feb; 256(2):645-9. PubMed ID: 1847206
[TBL] [Abstract][Full Text] [Related]
29. Calcium uptake by isolated sarcoplasmic reticulum: examination of halothane inhibition, pH dependence, and Ca2+ dependence of normal and malignant hyperthermic human muscle.
Blanck TJ; Gruener R; Suffecool SL; Thompson M
Anesth Analg; 1981 Jul; 60(7):492-8. PubMed ID: 7195664
[TBL] [Abstract][Full Text] [Related]
30. Abnormal uptake and release of Ca2+ ions from human malignant hyperthermia-susceptible sarcoplasmic reticulum.
O'Sullivan GH; McIntosh JM; Heffron JJ
Biochem Pharmacol; 2001 Jun; 61(12):1479-85. PubMed ID: 11377377
[TBL] [Abstract][Full Text] [Related]
31. Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ].
López JR; Contreras J; Linares N; Allen PD
Anesthesiology; 2000 Jun; 92(6):1799-806. PubMed ID: 10839932
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Ca2+-induced calcium release by isolated sarcoplasmic reticulum vesicles from malignant hyperthermia susceptible pig muscle.
Mickelson JR; Ross JA; Reed BK; Louis CF
Biochim Biophys Acta; 1986 Nov; 862(2):318-28. PubMed ID: 2877689
[TBL] [Abstract][Full Text] [Related]
33. Enhancing effect of calmodulin on Ca(2+)-induced Ca2+ release in the sarcoplasmic reticulum of rabbit skeletal muscle fibres.
Ikemoto T; Iino M; Endo M
J Physiol; 1995 Sep; 487 ( Pt 3)(Pt 3):573-82. PubMed ID: 8544122
[TBL] [Abstract][Full Text] [Related]
34. The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum.
Louis CF; Zualkernan K; Roghair T; Mickelson JR
Anesthesiology; 1992 Jul; 77(1):114-25. PubMed ID: 1609985
[TBL] [Abstract][Full Text] [Related]
35. Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals.
Chang L; Daly C; Miller DM; Allen PD; Boyle JP; Hopkins PM; Shaw MA
Br J Anaesth; 2019 May; 122(5):613-621. PubMed ID: 30916033
[TBL] [Abstract][Full Text] [Related]
36. FK506 (tacrolimus) increases halothane-induced Ca2+ release from skeletal muscle sarcoplasmic reticulum.
Chini EN; Walker H
Anesthesiology; 2000 May; 92(5):1361-5. PubMed ID: 10781282
[TBL] [Abstract][Full Text] [Related]
37. Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.
Wehner M; Rueffert H; Koenig F; Olthoff D
Genet Test; 2003; 7(3):203-11. PubMed ID: 14641996
[TBL] [Abstract][Full Text] [Related]
38. Effects of creatine phosphate on Ca2+ regulation by the sarcoplasmic reticulum in mechanically skinned rat skeletal muscle fibres.
Duke AM; Steele DS
J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):447-58. PubMed ID: 10332094
[TBL] [Abstract][Full Text] [Related]
39. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Metterlein T; Hartung E; Schuster F; Roewer N; Anetseder M
Minerva Anestesiol; 2011 Aug; 77(8):768-73. PubMed ID: 21730923
[TBL] [Abstract][Full Text] [Related]
40. Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane.
Snoeck MM; Gielen MJ; Tangerman A; van Egmond J; Dirksen R
Acta Anaesthesiol Scand; 2000 Mar; 44(3):334-7. PubMed ID: 10714850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
